Vogue Magazine – Who Shows Up—and Who Vanishes—When Your Kid Is in Trouble?
Who Shows Up—and Who Vanishes—When Your Kid Is in Trouble? By Jessica Slice September 9, 2026 This piece hit very close to home. I’ve been part of the autism community,...
ASPIRE Joins Joint Statement in Support of the 2026 IACC Strategic Plan
As a PANS/PANDAS organization, our involvement is important. PANS/PANDAS can occur in autistic individuals, and the Plan’s increased attention to co-occurring medical conditions and...
Why States Need to Require PANS/PANDAS Provider Education: The Cost of Inaction
Earlier Recognition Can Reduce Avoidable Harm and Expense PANS and PANDAS are immune-mediated conditions characterized by sudden or newly worsening neuropsychiatric symptoms, including...
Making Space for Grief in the PANS/PANDAS Community
National Grief Awareness Day is a good time to recognize a kind of grief that is often hard to describe. For those who have PANS and PANDAS and for the...
‘Brains on Fire:’ Advocates push for treatment of rare children’s syndrome
Bills would make Michigan the 17th state to mandate health coverage for treatment of syndrome tied to strep and other infections. Dozens of Michigan children with a rare psychiatric disorder...
New Research Identifies Autoantibodies and Altered Antiviral Immune Responses in a Subset of Children With PANS
Autoantibodies & Altered Antiviral Immune Responses in a Subset of Children With PANS A recent study conducted by researchers at Stanford University offers further evidence of immune...
IACC Policy Comments
The Interagency Autism Coordinating Committee (IACC) is a federal advisory group that coordinates autism research and services within the U.S. Department of Health and Human Services. The Committee...
Interferon-λ-neutralizing autoantibodies and common autoimmune disease autoantibodies in pediatric acute-onset neuropsychiatric syndrome
Yin X, Frankovich J, Kalaycioglu M, Choudhury A, Burry Jr. MJ, Kwon WJ, Tian L, Ma M, Farhadian B, Manko C, Silverman M, Xie Y, Tran P, Schlenk N, Utz PJ and Prestwood TR (2026) Interferon-λ-neutralizing autoantibodies and common autoimmune disease autoantibodies in pediatric acute-onset neuropsychiatric syndrome. Front. Immunol. 17:1832833. doi: 10.3389/fimmu.2026.1832833
- 166 children with PANS were compared with healthy pediatric controls using plasma collected during active flares.
- PANS patients had higher rates of autoantibodies associated with connective tissue, GI, and endocrine autoimmune diseases.
- A subset had autoantibodies targeting interferon lambda (IFN-λ), an important part of antiviral defense at mucosal/barrier surfaces.
- Functional testing showed that some IFN-λ autoantibodies reduced or neutralized IFN-λ signaling, suggesting potential impairment of antiviral immune responses.
- Findings add to evidence of immune dysregulation and autoimmunity in PANS and identify IFN-λ autoantibodies as an important area for further research.
- Researchers caution that these autoantibodies are not currently diagnostic biomarkers for PANS.
Mitigating Exposure to Forest Fire Smoke with Lindsey Wells, ND
When wildfire smoke affects air quality, this ASPIRE video with Lindsey Wells, ND, offers timely information on how smoke exposure can affect the body, as well as practical ways to...
Governor Lamont Bill Signing Ceremony for Public Act 26-33 (HB 5374) Concerning Insurance Coverage for Certain Health Conditions and Medical Treatments
Governor Lamont Bill Signing Ceremony for Public Act 26-33 (HB 5374) Concerning Insurance Coverage for Certain Health Conditions and Medical Treatments Recorded On: 7/14/2026 Watch Bill Signing...
Connecticut insurance now required to cover these medical treatments under Lamont
HARTFORD, Conn. (WTNH) — Gov. Ned Lamont (D) signed legislation Tuesday requiring Connecticut insurance policies to cover certain health conditions and medical treatments, ranging from prosthetic...